1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-
ARDS (Moderate or Severe)
University Medical Center GroningenSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the ARDS (Moderate or Severe) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Recombinant Human Keratinocyte Growth Factor-2 For Inhalation Shanghai Zhongshan Hospital | Early Phase 1 | C |
FALLYPRIDE University Medical Center Groningen | D |
Same molecule, other indications
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →